SYNERGISTIC OPHTHALMOLOGICAL COMPOSITION IN A LOW-CONCENTRATION DOSE THAT IS EFFECTIVE IN THE PREVENTION, CONTROL AND ERADICATION OF PRESBYOPIA

An ophthalmic composition for the prevention, control and treatment of presbyopia symptoms comprising a synergistic combination of pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac and optionally a vasoconstrictor in a single low concentration dose to improve near vision ability an...

Full description

Saved in:
Bibliographic Details
Main Author SÁNCHEZ GALEANA, Cesar Alejandro
Format Patent
LanguageEnglish
Published 28.12.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:An ophthalmic composition for the prevention, control and treatment of presbyopia symptoms comprising a synergistic combination of pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac and optionally a vasoconstrictor in a single low concentration dose to improve near vision ability and increase depth of focus is described. In addition, the side effects of pilocarpine administered separately, such as eye redness, headache, and dryness of the eye, are reduced and are better tolerated in patients suffering from presbyopia.
Bibliography:Application Number: US202118036666